TEVA
TEVA
US8816242098
Teva Pharmaceutical Industries
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 17.257.000.000 16.544.000.000
4.3%
Cost of Revenue 8.320.000.000 8.481.000.000
1.9%
Gross Profit 8.938.000.000 8.064.000.000
10.8%
4.986.000.000 4.700.000.000
6.1%
Operating Income 3.952.000.000 3.364.000.000
17.5%
Pretax Income 1.223.000.000 -1.284.000.000
195.2%
Net Income Common Stockholders 1.410.000.000 -1.639.000.000
186.0%
-- --
--
-- --
--
ende